These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27000504)

  • 1. Introduction and Clinical Overview of the DVH Risk Map.
    Asbell SO; Grimm J; Xue J; Chew MS; LaCouture TA
    Semin Radiat Oncol; 2016 Apr; 26(2):89-96. PubMed ID: 27000504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of Current Stereotactic Body Radiation Therapy Dose Constraints for Aorta and Major Vessels.
    Xue J; Kubicek G; Patel A; Goldsmith B; Asbell SO; LaCouture TA
    Semin Radiat Oncol; 2016 Apr; 26(2):135-9. PubMed ID: 27000510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Bowel Dose Tolerance for Stereotactic Body Radiation Therapy.
    LaCouture TA; Xue J; Subedi G; Xu Q; Lee JT; Kubicek G; Asbell SO
    Semin Radiat Oncol; 2016 Apr; 26(2):157-64. PubMed ID: 27000513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated Risk Level of Unified Stereotactic Body Radiation Therapy Dose Tolerance Limits for Spinal Cord.
    Grimm J; Sahgal A; Soltys SG; Luxton G; Patel A; Herbert S; Xue J; Ma L; Yorke E; Adler JR; Gibbs IC
    Semin Radiat Oncol; 2016 Apr; 26(2):165-71. PubMed ID: 27000514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-Response Model for Chest Wall Tolerance of Stereotactic Body Radiation Therapy.
    Kimsey F; McKay J; Gefter J; Milano MT; Moiseenko V; Grimm J; Berg R
    Semin Radiat Oncol; 2016 Apr; 26(2):129-34. PubMed ID: 27000509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic Radiosurgery.
    Hiniker SM; Modlin LA; Choi CY; Atalar B; Seiger K; Binkley MS; Harris JP; Liao YJ; Fischbein N; Wang L; Ho A; Lo A; Chang SD; Harsh GR; Gibbs IC; Hancock SL; Li G; Adler JR; Soltys SG
    Semin Radiat Oncol; 2016 Apr; 26(2):97-104. PubMed ID: 27000505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-Volume Histogram Analysis of Stereotactic Body Radiotherapy Treatment of Pancreatic Cancer: A Focus on Duodenal Dose Constraints.
    Goldsmith C; Price P; Cross T; Loughlin S; Cowley I; Plowman N
    Semin Radiat Oncol; 2016 Apr; 26(2):149-56. PubMed ID: 27000512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delineation of organs at risk and dose constraints].
    Noël G; Antoni D; Barillot I; Chauvet B
    Cancer Radiother; 2016 Sep; 20 Suppl():S36-60. PubMed ID: 27516050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-defining rectal volume and DVH for analysis of rectal morbidity risk after radiotherapy for early prostate cancer.
    O'Donnell HE; Finnegan K; Eliades H; Oliveros S; Plowman PN
    Br J Radiol; 2008 Apr; 81(964):327-32. PubMed ID: 18344276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.
    Pettersson N; Nyman J; Johansson KA
    Radiother Oncol; 2009 Jun; 91(3):360-8. PubMed ID: 19410314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy.
    Grimm J; LaCouture T; Croce R; Yeo I; Zhu Y; Xue J
    J Appl Clin Med Phys; 2011 Feb; 12(2):3368. PubMed ID: 21587185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
    Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
    Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.
    Rwigema JC; Nguyen D; Heron DE; Chen AM; Lee P; Wang PC; Vargo JA; Low DA; Huq MS; Tenn S; Steinberg ML; Kupelian P; Sheng K
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):401-9. PubMed ID: 25482301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case.
    Esposito M; Maggi G; Marino C; Bottalico L; Cagni E; Carbonini C; Casale M; Clemente S; D'Alesio V; Fedele D; Giglioli FR; Landoni V; Martinotti A; Nigro R; Strigari L; Villaggi E; Mancosu P
    Phys Med; 2016 Jan; 32(1):277-83. PubMed ID: 26498378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
    Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Importance of Quasi-4D Path-Integrated Dose Accumulation for More Accurate Risk Estimation in Stereotactic Liver Radiotherapy.
    Taylor ML; Yeo UA; Supple J; Keehan S; Siva S; Kron T; Pham D; Haworth A; Franich RD
    Technol Cancer Res Treat; 2016 Jun; 15(3):428-36. PubMed ID: 25994795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical dose and toxicity index of organs at risk in radiotherapy: analyzing the calculated effects of modified dose fractionation in non-small cell lung cancer.
    Pedicini P; Strigari L; Benassi M; Caivano R; Fiorentino A; Nappi A; Salvatore M; Storto G
    Med Dosim; 2014; 39(1):23-30. PubMed ID: 24239409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic ablative body radiation therapy with dynamic conformal multiple arc therapy for liver tumors: optimal isodose line fitting to the planning target volume.
    Oku Y; Takeda A; Sanuki N; Sudo Y; Oooka Y; Aoki Y; Shimouchi Y; Nishina R; Nomura K; Eriguchi T; Kunieda E
    Pract Radiat Oncol; 2014; 4(1):e7-e13. PubMed ID: 24621435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical appraisal of volumetric modulated arc therapy in stereotactic body radiation therapy for metastases to abdominal lymph nodes.
    Bignardi M; Cozzi L; Fogliata A; Lattuada P; Mancosu P; Navarria P; Urso G; Vigorito S; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1570-7. PubMed ID: 19880261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red shell: defining a high-risk zone of normal tissue damage in stereotactic body radiation therapy.
    Yang J; Fowler JF; Lamond JP; Lanciano R; Feng J; Brady LW
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):903-9. PubMed ID: 20400240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.